Breaking News

Hoth Therapeutics Deploys OpenAI API to Support Development of HT-KIT

The OpenAI-powered API platform has been integrated into the HT-KIT development workflow.

Author Image

By: Charlie Sternberg

Associate Editor

Hoth Therapeutics Inc., a patient-focused biopharmaceutical company advancing breakthrough therapies for diseases, has deployed the OpenAI API to support IND-enabling development of HT-KIT, its orphan-designated therapy targeting rare and aggressive KIT-driven cancers. The OpenAI-powered API platform has been integrated into the HT-KIT development workflow to support preclinical data analysis, molecular modeling of KIT-driven pathways, and preparation of regulatory documentation ahead of IND ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters